Sign In
Buy INSP
$59.72
-0.440 (-0.731%)
At Close: Aug 10, 2026
Assenagon Asset Management S.A. Increases Holdings in Inspire Medical Systems, Inc. $INSP
04:11am, Sunday, 09'th Aug 2026
Assenagon Asset Management S.A. increased its position in Inspire Medical Systems, Inc. (NYSE: INSP) by 66.2% during the second quarter, according to the company in its most recent 13F filing with the
Is INSP a Buy as Margins Improve but Reimbursement Risks Persist?
03:01pm, Wednesday, 05'th Aug 2026
Inspire Medical's vast sleep apnea opportunity, rising margins and debt-free balance sheet support patience as reimbursement issues weigh on procedures.
INSP Raises 2026 Outlook as Reimbursement Headwinds Start to Ease
03:01pm, Wednesday, 05'th Aug 2026
Inspire Medical raised its 2026 outlook after a Q2 beat, as Inspire V mix and cost control offset weak U.S. procedure activity.
INSP's 28.1% Past-Month Rally Raises a Key Question for Investors
02:36pm, Wednesday, 05'th Aug 2026
Inspire Medical shares jumped 28.1% as an earnings beat, raised 2026 guidance and estimate revisions offset reimbursement pressure.
Amundi Sells 107,792 Shares of Inspire Medical Systems, Inc. $INSP
03:07am, Wednesday, 05'th Aug 2026
Amundi trimmed its holdings in Inspire Medical Systems, Inc. (NYSE: INSP) by 29.6% during the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commissio
Inspire Medical Q2 Earnings Beat Estimates, '26 View Raised, Stock Up
02:01pm, Tuesday, 04'th Aug 2026
INSP beats second-quarter estimates, raises its 2026 outlook and sees shares jump despite U.S. reimbursement pressures and lower revenues.
Inspire Medical Systems Analysts Raise Their Forecasts Following Strong Q2 Results
08:14am, Tuesday, 04'th Aug 2026
Inspire Medical Systems Inc (NYSE:INSP) on Monday reported better-than-expected second-quarter financial results and raised its FY26 guidance.
Inspire Medical Systems, Inc. (INSP) Q2 2026 Earnings Call Transcript
02:30am, Tuesday, 04'th Aug 2026
Inspire Medical Systems, Inc. (INSP) Q2 2026 Earnings Call Transcript
Inspire Medical Systems Q2 Earnings Call Highlights
08:05pm, Monday, 03'rd Aug 2026
Inspire Medical Systems NYSE: INSP reported second-quarter revenue of $200.6 million, down 7.6% from a year earlier, as coding and reimbursement disruptions continued to affect procedure volumes. The
Compared to Estimates, Inspire (INSP) Q2 Earnings: A Look at Key Metrics
07:01pm, Monday, 03'rd Aug 2026
The headline numbers for Inspire (INSP) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates
Inspire Medical Systems (INSP) Q2 Earnings and Revenues Beat Estimates
06:46pm, Monday, 03'rd Aug 2026
Inspire Medical Systems (INSP) came out with quarterly earnings of $0.14 per share, beating the Zacks Consensus Estimate of a loss of $0.22 per share. This compares to earnings of $0.45 per share a ye
Inspire Medical Systems, Inc. Announces Second Quarter 2026 Financial Results, Raised 2026 Guidance, and Strategic Growth Plan
04:02pm, Monday, 03'rd Aug 2026
Generated second quarter revenue of $200.6 million Second quarter diluted EPS of $0.01; adjusted diluted EPS of $0.14 Second quarter operating cash flow of $23.2 million Announced strategic growth pla
Inspire Medical Systems, Inc. $INSP Stake Boosted by Bank of Nova Scotia
04:03am, Wednesday, 29'th Jul 2026
Bank of Nova Scotia boosted its stake in shares of Inspire Medical Systems, Inc. (NYSE: INSP) by 49.8% during the undefined quarter, according to the company in its most recent filing with the Securit
MINNEAPOLIS, July 27, 2026 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP), a medical technology company focused on innovative, minimally invasive solutions for patients with obstructiv
NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF continues
